Technology | October 27, 2010

Software Records Pulmonary Angiography Contrast Dose

P3T PA (pulmonary angiography), from Medrad, is a personalized contrast-dosing software that increases the percentage of diagnostic-quality CT pulmonary angiography (CTPA) studies to rule out pulmonary embolism (PE).

Researchers have concluded that suboptimal CTPA interpretations to rule out PE can substantially impact healthcare resource utilization and increase healthcare costs. With 30 percent of their CTPA studies showing suboptimal results, these patients were subjected to additional imaging studies and/or received medical therapy. Some patients were admitted to the hospital for further PE diagnosis considerations. None of the additional treatments or imaging modalities yielded a diagnosis of PE.

P3T PA fits into the established workflow and offers flexibility and efficiency in optimizing each patient’s contrast dose -- especially when operating higher-speed scanners. The P3T algorithm tailors each patient’s contrast protocol based on technologists’ touch-screen responses to unique clinical concerns, study requirements and the scanning equipment used.

It is the third module in the company’s P3T software line, which also includes cardiac and abdominal CT modules that automate each patient’s optimal contrast dose for studies addressing these areas of the anatomy.

For more information: www.medrad.com

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
Veterans Integrated Service Network 19 Implements System-Wide Radiation Dose Monitoring
News | Radiation Dose Management | December 04, 2018
Agfa HealthCare announced it has collaborated in delivering a system-wide DoseMonitor automated software implementation...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
Infervision Introduces AI Capabilities for Chest CT Reading
Technology | Computer-Aided Detection Software | November 30, 2018
Big data and artificial intelligence (AI) company Infervision announced the launch of InferRead CT Chest, a new product...
University of Utah Health Radiologists Select Philips Illumeo for Adaptive Intelligence
News | Artificial Intelligence | November 30, 2018
At the 2018 Radiological Society of North America (RSNA) Annual Meeting, Philips announced radiologists at the...
NeuroLogica and MaxQ AI Announce Distribution Agreement
News | Stroke | November 30, 2018
Clinical diagnostics intelligence platform company MaxQ AI and Samsung NeuroLogica announced a distribution agreement...